Dr. Patrick McGlynn, MD

Dr. McGlynn practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. McGlynn's NPI, 1124317540, was assigned on April 6, 2011. Dr. McGlynn graduated from Royal College of Surgeons Ireland in 2011. Dr. McGlynn holds California license A162992.

Dr. McGlynn's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. McGlynn's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. McGlynn is also affiliated with El Camino Health - Mountain View Hospital. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. McGlynn to 1 more hospital, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGlynn practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. McGlynn's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. McGlynn's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances and kidney cysts among the conditions Dr. McGlynn treats.

CMS data shows 1,107 Medicare services from Dr. McGlynn across 13 procedure codes in 2024, for 343 Medicare patients. Medicare paid $132,191 for them.

CMS counts 343 Medicare patients who saw Dr. McGlynn in 2024. The largest group is 75 to 84, with 125 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 3.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McGlynn's median patient age at 70, with 40% women.

In 2024, Dr. McGlynn wrote 1,074 Medicare Part D claims for 197 patients. 92% of them were for generic drugs. CMS names the drug for 863 of them, across 22 drugs with 11 or more claims each, at $68,123 in total drug cost. In 2023, CMS named 676 claims across 18 drugs.

Dr. McGlynn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McGlynn as offering telehealth.

Dmand AI links 2 papers to Dr. McGlynn in 2017. The most frequent topics are Arteriovenous Shunt, Surgical, Blood Vessel Prosthesis Implantation and Renal Dialysis. Dr. McGlynn has published most often in J Vasc Surg. Dr. McGlynn's most frequent co-authors are Dirk M. Hentschel, MD, C Keith Ozaki, MD and Michael Belkin, MD.

CMS Open Payments shows 5 general payments to Dr. McGlynn from 4 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 96% of the total. Calliditas Therapeutics US Inc. paid the most, $139.

Dr. McGlynn graduated from Royal College of Surgeons Ireland in 2011.

Dr. McGlynn is in network with 13 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.